Cancer news

Latest news, press releases and blog posts from Cancer Research UK.


Immunotherapy drug combination shows promise for advanced melanoma patients

Two immunotherapy drugs could be better than one - at least for a subset of patients with advanced melanoma.

New drug to enter trials for drug-resistant blood cancer patients

Researchers have developed an experimental treatment to overcome resistance to drugs used to treat cancers of the blood.

Study confirms long-term benefits of melanoma immunotherapy

A long-term follow up of people on a clinical trial has confirmed the benefit of immunotherapy for some patients with advanced melanoma.

The Enemy Within – 50 years of fighting cancer

Cancer has always been with us, affecting our species for many thousands of years. For most of that time there was little we could do in the face of such a powerful...

Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in other cancers

Cancer Research UK, Cancer Research Technology and Amgen to trial leukaemia immunotherapy drug in patients with soild tuimours.

Crowdfunding cancer research – our latest experiment and how you can help

Can you help a research team grow 3D lung tissue in a lab to help study cancer? Can we track how moving skin cancer cells give the immune system the slip? Or is there a...

NCRI 2014 conference summary – day 3

A look through the morning’s media coverage surfaced these reports from the conference:

This story about emergency lung cancer diagnoses appeared in the Times. New...

Biotherapeutics – a new funding scheme for research

We’ve come a long way from the early days of treating cancer in the 1950s and 60s. Back then, the main options for treatment were relatively unrefined radiotherapy and...

Immunotherapy could stop resistance to radiotherapy

Treating cancers with immunotherapy and radiotherapy at the same time could stop them from becoming resistant to treatment.

Calming down immune cells could hold key to melanoma treatment

Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.